The obesity pandemic is accelerating the risk of diabetes, non-alcoholic fatty liver disease (NAFLD), cardio- vascular diseases and other ailments. PPARa agonist drugs are prescribed to promote fat loss and amelio- rate hepatic steatosis and insulin resistance by activating gene programs driving mitochondrial b-oxidation. Effects of PPARa agonists in the liver are enhanced by remodeling the action of MAMs, cytoplasmic struc- tures that foster exchange of Ca2+ and phospholipids between the mitochondrion and endoplasmic reticu- lum. The master mTORC2/Akt signaling node localizes to the MAM where it coordinates PPARa and MAM actions through an unknown mechanism. Therefore, understanding how mTORC2/Akt regulates PPARa and MAMs in the liver is crucial to developing new approaches to combat the obesity epidemic. Our long- term goal is to understand how nuclear gene expression and cytoplasmic ER/mitochondrial activity are coor- dinated to control energy homeostasis in humans. The objective of this particular application is to determine how mTORC2/Akt-mediated phosphorylation of the multi-functional protein PACS-2 Ser437 combines with PACS-2 nuclear trafficking signals to coordinate PPARa transcriptional activity with MAM-dependent calci- um exchange in response to fasting or a high fat diet. Our central hypothesis is that in response to overeat- ing, mTORC2/Akt-phosphorylated PACS-2 sequesters PPARa in the cytoplasm and increases MAMs, there- by repressing genes controlling fatty acid oxidation while inducing calcium overload in mitochondria. These combined effects cause steatosis and insulin resistance. By contrast, fasting silences mTORC2/Akt signal- ing, triggering PACS-2 dephosphorylation. Consequently, PPARa is liberated and MAMs are remodeled, which combine to increase fatty acid oxidation and support fasting-induced autophagy. Guided by strong preliminary data, we will test our hypothesis by pursuing three specific aims: 1) Determine how liver PACS- 2 coordinates PPARa-dependent gene expression with MAM remodeling to regulate fatty acid oxidation; 2) Determine how mTOR/Akt controls PACS-2 regulation of PGC-1a/PPARa activity; and 3) Determine how PACS-2 regulates access of PPARa to the nucleus. The approach is innovative because it will combine in vivo models of overnutrition and fasting together with studies on gene expression, ER-mitochondria commu- nication, mitochondrial oxygen consumption and live-cell imaging to describe a novel and previously unrec- ognized pathway controlling the response to fasting or a high fat diet. This research is significant because it will advance our understanding of how mTORC2/Akt controls PACS-2 Ser437 to act as a molecular switch to coordinate vital, homeostatic transcriptional and mitochondrial responses to nutrient stresses.

Public Health Relevance

The proposed research is relevant to public health because understanding the molecular pathways controlling diet-induced obesity and its comorbidity may lead to novel therapeutic interventions that can be used to treat NAFLD, dyslipidemia and diabetes. Thus, the proposed research is relevant to the part of NIH's mission supporting fundamental research that will ultimately cure disease.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Silva, Corinne M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Krzysiak, Troy C; Thomas, Laurel; Choi, You-Jin et al. (2018) An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity. Mol Cell 72:985-998.e7
Olson, Heather E; Jean-Marçais, Nolwenn; Yang, Edward et al. (2018) A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am J Hum Genet 102:995-1007
Kveiborg, Marie; Thomas, Gary (2018) PACS-2 functions in colorectal cancer. Aging (Albany NY) 10:1190-1191
Dombernowsky, Sarah L; Schwarz, Jeanette; Samsøe-Petersen, Jacob et al. (2017) Loss of PACS-2 delays regeneration in DSS-induced colitis but does not affect the ApcMin model of colorectal cancer. Oncotarget 8:108303-108315
Thomas, Gary; Aslan, Joseph E; Thomas, Laurel et al. (2017) Caught in the act - protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease. J Cell Sci 130:1865-1876